BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• Georgia Bio Deals Of The Year Spotlight Financings, Acquisitions And Collaboration

  December 19, 2014

   · 

  1 min read
• Drug Development

  Galapagos NV Initiates First Phase 1 Study In Cystic Fibrosis And Will Receive Milestone Payment From AbbVie

  December 19, 2014

   · 

  3 min read
• Anergis Granted U.S. Patent For Ragweed Allergy Vaccine AllerR

  December 19, 2014

   · 

  3 min read
• Pharm Country

  Alzheimer’s Drug Discovery Foundation Release: US Nonprofit Awards Italian Biotech Additional Funding To Study New Class Of Drugs To Treat Alzheimer’s Disease

  December 19, 2014

   · 

  2 min read
• Business

  PreventionGenetics LLC Teams Up With Seattle Children’s Hospital PLUGS Program To Enhance Utilization Management

  December 19, 2014

   · 

  1 min read
• Lone Star Bio

  PlasmaTech Biopharmaceuticals Announces Pricing Of $14,000,000 Public Offering And Listing On NASDAQ

  December 19, 2014

   · 

  3 min read
• Australian Presence Of Elekta’s Versa HD Radiation Therapy System Grows

  December 19, 2014

   · 

  4 min read
• BioMidwest

  Aratana Therapeutics Announces Positive Top-Line Results From AT-001 Pivotal Field Study In Client-Owned Dogs With Osteoarthritis

  December 19, 2014

   · 

  6 min read
• Drug Development

  Halozyme Therapeutics, Inc. Receives European Orphan Drug Designation For PEGylated Recombinant Human Hyaluronidase PH20 For Pancreatic Cancer

  December 19, 2014

   · 

  3 min read
• AEterna Zentaris Receives Notification From NASDAQ Relating To Minimum Bid Price

  December 19, 2014

   · 

  3 min read